No Data
No Data
EClinical Solutions to Highlight Successful Approaches for AI-Driven Clinical Trial Productivity at Citeline Roundtable, DIA, and More
Company will share clinical data transformation expertise alongside other life science heavyweights, as part of busy summer events circuitBOSTON--(BUSINESS WIRE)--eClinical Solutions LLC, a global pro
Express News | Indaptus Therapeutics To Present At STING & TLR-Targeted Therapies Summit Jun. 19-20
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersVenus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday's pre-market session. The market value of their outstanding shares is at $8.7 million. Adlai Nortye (NASDAQ:ANL) sh
Indaptus Therapeutics To Present New Positive Data On Decoy20 At Next-Gen Immuno-Oncology Conference
Indaptus Therapeutics, Inc, (NASDAQ:INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Offic
Express News | Indaptus Therapeutics Announces New Positive Data From Ongoing Phase 1 Trial of Decoy20
Express News | Indaptus Therapeutics Presents New Cohort Data Confirming Original "Pulse-Prime" Hypothesis Via Phase 1 Clinical Trial Of Decoy20 At The ASCO Annual Meeting
No Data
70125061 : Volume blows
TrytosaveabitOP 70125061: 2 things! PM and the other is the conference isn’t until June 20th! GL
买跌不追涨 : not active
TrytosaveabitOP 买跌不追涨: Didn’t expect it to be until June 20th or so!